SAN

86.26

-0.06%↓

MRK1

115.55

+2.44%↑

ARGX

782.2

-0.23%↓

PHIA

23.99

+1.14%↑

ONC.US

335.23

+1.26%↑

SAN

86.26

-0.06%↓

MRK1

115.55

+2.44%↑

ARGX

782.2

-0.23%↓

PHIA

23.99

+1.14%↑

ONC.US

335.23

+1.26%↑

SAN

86.26

-0.06%↓

MRK1

115.55

+2.44%↑

ARGX

782.2

-0.23%↓

PHIA

23.99

+1.14%↑

ONC.US

335.23

+1.26%↑

SAN

86.26

-0.06%↓

MRK1

115.55

+2.44%↑

ARGX

782.2

-0.23%↓

PHIA

23.99

+1.14%↑

ONC.US

335.23

+1.26%↑

SAN

86.26

-0.06%↓

MRK1

115.55

+2.44%↑

ARGX

782.2

-0.23%↓

PHIA

23.99

+1.14%↑

ONC.US

335.23

+1.26%↑

Home・Aktien・Pharming Group NV

P
Pharming Group NV

Geschlossen

1.472 0.68

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.435

Max

1.4849999999999999

Schlüsselkennzahlen
By Trading Economics
Einkommen	2.9M 7.5M
Verkäufe	4.1M 97M
EPS	0.009
Gewinnspanne	7.758
Angestellte	404

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-43M 954M
Vorheriger Eröffnungskurs	0.79
Vorheriger Schlusskurs	1.472

Pharming Group NV Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Nov. 2025, 16:56 UTC

Ergebnisse

Wichtige Markttreiber

Alimentation Couche-Tard Shares Rise as 2Q Same-Store Sales Support Profit Growth

25. Nov. 2025, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25. Nov. 2025, 23:47 UTC

Market Talk

Nikkei May Rise After Stock Gains on Wall Street -- Market Talk

25. Nov. 2025, 22:39 UTC

Market Talk

Global Equities Roundup: Market Talk

25. Nov. 2025, 22:39 UTC

Market Talk

Vault Accelerates Exposure to Spot Gold Prices by Six Months -- Market Talk

25. Nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

25. Nov. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

25. Nov. 2025, 21:38 UTC

Ergebnisse

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25. Nov. 2025, 21:31 UTC

Market Talk

F&P Healthcare's Share Price Jumps on Profit Guidance Upgrade -- Market Talk

25. Nov. 2025, 21:27 UTC

Ergebnisse

These Stocks Moved the Most Today: Nvidia, AMD, Alphabet, Abercrombie, Kohl's, Novo Nordisk, Symbotic, and More -- Barrons.com

25. Nov. 2025, 21:20 UTC

Ergebnisse

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25. Nov. 2025, 21:18 UTC

Ergebnisse

NIO Stock Drops as EV Maker Posts Narrower Loss -- Barrons.com

25. Nov. 2025, 21:15 UTC

Ergebnisse

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25. Nov. 2025, 20:16 UTC

Market Talk

U.S. Natural Gas Falls as December Contract Expires -- Market Talk

25. Nov. 2025, 18:42 UTC

Market Talk

USDA Backs Mexican Retail Expo to Raise Agricultural Exports -- Market Talk

25. Nov. 2025, 18:25 UTC

Akquisitionen, Fusionen, Übernahmen

S&P Global Completes $1.8 Billion Acquisition Of With Intelligence, Strengthening Its Position As A Leader In Private Markets Data & Analytics >SPGI

25. Nov. 2025, 17:30 UTC

Market Talk

Mexico Posts Record Foreign Direct Investment for Jan-Sep -- Market Talk

25. Nov. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

25. Nov. 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

25. Nov. 2025, 16:33 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Financial Details Weren't Disclosed

25. Nov. 2025, 16:33 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Block OFF-5 Covers an Area of About 17,000 Km Sq. in Water Depths

25. Nov. 2025, 16:32 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Agreement to Become Effective After Approval of Uruguayan Authorities

25. Nov. 2025, 16:31 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Acquisition Is for a 50% Share, Operatorship in Exploration Block OFF-5

25. Nov. 2025, 16:30 UTC

Akquisitionen, Fusionen, Übernahmen

Eni Acquires From YPF Shares in the Exploration Block OFF-5 Offshore Uruguay

25. Nov. 2025, 16:23 UTC

Ergebnisse

This Robotics Stock Soars 40% on Earnings. Here's Why. -- Barrons.com

25. Nov. 2025, 16:12 UTC

Market Talk

Euro Expected to Rise to $1.25 in 2026: Deutsche Bank -- Market Talk

25. Nov. 2025, 16:11 UTC

Market Talk

Dollar Could Take One Final Leg Lower in Early 2026 -- Market Talk

25. Nov. 2025, 16:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25. Nov. 2025, 16:10 UTC

Market Talk

Sterling Could Briefly Rise After Budget -- Market Talk

25. Nov. 2025, 16:10 UTC

Market Talk

Oil Extends Losses on Ukraine-Russia Peace Deal Hopes -- Market Talk

Peer-Vergleich

Kursveränderung

Pharming Group NV Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pharming Group NV – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.